ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,612Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 939

$1.15M Total Retail Price of All Prescriptions

Rank: 28 out of 939

604 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 604 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 604 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 19,866 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 890 434 S3 1 1
POTASSIUM CHLORIDE 841 719 2 9
FUROSEMIDE 753 661 3 7
LISINOPRIL 737 616 4 3
SIMVASTATIN 694 548 5 2
LEVOTHYROXINE SODIUM 680 554 6 4
LOVASTATIN 626 542 7 46
PRAVASTATIN SODIUM 533 418 8 13
SERTRALINE HCL 526 429 9 24
GABAPENTIN 518 405 10 11
TRAZODONE HCL 460 320 11 26
OMEPRAZOLE 442 328 12 5
AMLODIPINE BESYLATE 361 308 13 6
NABUMETONE 351 271 14 152
METOPROLOL TARTRATE 345 308 15 10
ALENDRONATE SODIUM 334 308 16 40
MELOXICAM 328 258 17 14
DONEPEZIL HCL 327 327 18 30
METOPROLOL SUCCINATE 320 283 19 21
METFORMIN HCL 311 238 20 8
CITALOPRAM HBR 294 236 21 15
SUCRALFATE 285 234 22 96
WARFARIN SODIUM 280 264 23 17
CLOPIDOGREL 274 256 24 28
FAMOTIDINE 265 220 25 62
GLIMEPIRIDE 259 168 26 37
CRESTOR 246 197 27 34
ISOSORBIDE MONONITRATE ER 232 206 28 53
NEXIUM 219 166 29 18
PLAVIX 219 208 29 48
ATENOLOL 216 142 31 19
NAMENDA 211 211 32 49
ATORVASTATIN CALCIUM 211 153 32 22
LOSARTAN POTASSIUM 210 171 34 29
VERAPAMIL ER 198 128 35 85
CARISOPRODOL 195 43 R 36 51
TAMSULOSIN HCL 194 190 37 27
TRIAMTERENE-HCTZ 194 160 37 33
ALLOPURINOL 193 151 39 31
PANTOPRAZOLE SODIUM 190 153 40 66
RISPERIDONE 185 160 41 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 147 42 23
AMITRIPTYLINE HCL 178 90 R 43 38
TRAMADOL HCL 177 120 44 16
QUETIAPINE FUMARATE 167 157 45 69
PAROXETINE HCL 156 89 46 70
BUMETANIDE 149 112 47 124
FENOFIBRATE 148 91 48 83
RANITIDINE HCL 144 101 49 35
PHENYTOIN SODIUM EXTENDED 140 98 50 99
DIGOXIN 140 127 50 45
PREDNISONE 139 98 52 42
HYDROCHLOROTHIAZIDE 137 137 53 12
CYCLOBENZAPRINE HCL 132 68 R 54 36
ADVAIR DISKUS 128 106 55 60
ENALAPRIL MALEATE 120 103 56 65
CYMBALTA 118 67 57 44
KLOR-CON M20 108 90 58 90
FLUOXETINE HCL 107 88 59 47
NAPROXEN 107 53 59 72
ACETAMINOPHEN-CODEINE 106 88 S3 61 116
CEPHALEXIN 103 65 62 77
BUPROPION XL 94 61 63 179
AMOXICILLIN 94 66 63 92
CLOTRIMAZOLE-BETAMETHASONE 92 58 65 188
GLYBURIDE-METFORMIN HCL 92 92 R 65 98
PROMETHAZINE HCL 89 34 R 67 68
CIPROFLOXACIN HCL 89 65 67 54
OXYBUTYNIN CHLORIDE 85 69 69 125
THEOPHYLLINE ANHYDROUS 85 72 69 225
LYRICA 85 32 69 63
SEROQUEL 84 80 72 139
KLOR-CON 10 82 71 73 158
ZETIA 80 57 74 103
ACTOS 80 60 74 141
SULINDAC 79 60 76 226
SPIRONOLACTONE 78 68 77 71
SINGULAIR 78 59 77 101
MIRTAZAPINE 77 57 79 56
DETROL LA 76 66 80 155
HUMULIN 70-30 74 42 81 200
BUPROPION HCL SR 74 43 81 196
PREMARIN 73 57 R 83 111
TRIAMTERENE-HYDROCHLOROTHIAZID 72 62 84 115
ZOLPIDEM TARTRATE 72 67 84 20
METOCLOPRAMIDE HCL 70 52 86 119
CELEBREX 68 51 87 106
LIPITOR 66 45 88 127
DIOVAN 66 43 88 50
IBUPROFEN 65 55 90 112
EXELON 63 63 91 151
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 53 92 64
TIZANIDINE HCL 60 40 93 81
METHYLPREDNISOLONE 58 48 94 118
LOSARTAN-HYDROCHLOROTHIAZIDE 58 36 94 55
CARBIDOPA-LEVODOPA 57 57 96 102
DIOVAN HCT 57 26 96 74
CALCITONIN-SALMON 57 47 96 289
CARVEDILOL 56 50 99 25
SYNTHROID 56 41 99 75
CLONIDINE HCL 55 53 101 39
INSULIN SYRINGE 55 47 101 97
FINASTERIDE 54 54 103 131
ESTRADIOL 53 26 R 104 79
FLUOCINONIDE 53 40 104 341
NOVOLIN 70-30 53 39 104 211
TERAZOSIN HCL 53 53 104 114
FLUTICASONE PROPIONATE 52 44 108 43
ESCITALOPRAM OXALATE 51 48 109 61
HYDROXYCHLOROQUINE SULFATE 51 38 109 323
TORSEMIDE 50 50 111 184
JANUVIA 50 34 111 110
COMBIVENT 50 38 111 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.